Literature DB >> 21800155

Small bowel evaluation in asymptomatic fecal immunochemical test-positive patients with a negative colonoscopy: is it necessary?

Jae Jun Park, Jae Hee Cheon.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21800155     DOI： 10.1007/s10620-011-1837-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  22 in total

1.  Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.

Authors:  Thomas F Imperiale; David F Ransohoff; Steven H Itzkowitz; Barry A Turnbull; Michael E Ross
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

2.  Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants.

Authors:  Zohar Levi; Paul Rozen; Rachel Hazazi; Alex Vilkin; Amal Waked; Eran Maoz; Shlomo Birkenfeld; Nicky Lieberman; Shmuel Klang; Yaron Niv
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

Review 3.  Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.

Authors:  Paul Hewitson; Paul Glasziou; Eila Watson; Bernie Towler; Les Irwig
Journal:  Am J Gastroenterol       Date:  2008-05-13       Impact factor: 10.864

4.  Is it worthwhile to perform capsule endoscopy for asymptomatic patients with positive immunochemical faecal occult blood test?

Authors:  Hideyuki Chiba; Masau Sekiguchi; Takafumi Ito; Yosuke Tsuji; Ken Ohata; Akiko Ohno; Shotaro Umezawa; Suguru Takeuchi; Kantaro Hisatomi; Takuma Teratani; Nobuyuki Matsuhashi; Hiroki Endo; Masahiko Inamori; Atsushi Nakajima
Journal:  Dig Dis Sci       Date:  2011-06-25       Impact factor: 3.199

5.  What is the learning curve associated with double-balloon enteroscopy? Technical details and early experience in 6 U.S. tertiary care centers.

Authors:  Shahab Mehdizadeh; Andrew Ross; Lauren Gerson; Jonathan Leighton; Ann Chen; Drew Schembre; Gary Chen; Carol Semrad; Ahmad Kamal; Edwyn M Harrison; Kenneth Binmoeller; Irving Waxman; Richard Kozarek; Simon K Lo
Journal:  Gastrointest Endosc       Date:  2006-11       Impact factor: 9.427

Review 6.  Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.

Authors:  Michael J Duffy; Leo G M van Rossum; Sietze T van Turenhout; Outi Malminiemi; Catherine Sturgeon; Rolf Lamerz; Andrea Nicolini; Caj Haglund; Lubos Holubec; Callum G Fraser; Stephen P Halloran
Journal:  Int J Cancer       Date:  2011-01-01       Impact factor: 7.396

7.  A quantitative immunochemical fecal occult blood test for colorectal neoplasia.

Authors:  Zohar Levi; Paul Rozen; Rachel Hazazi; Alex Vilkin; Amal Waked; Eran Maoz; Shlomo Birkenfeld; Moshe Leshno; Yaron Niv
Journal:  Ann Intern Med       Date:  2007-02-20       Impact factor: 25.391

Review 8.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

9.  Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Authors:  James E Allison; Lori C Sakoda; Theodore R Levin; Jo P Tucker; Irene S Tekawa; Thomas Cuff; Mary Pat Pauly; Lyle Shlager; Albert M Palitz; Wei K Zhao; J Sanford Schwartz; David F Ransohoff; Joseph V Selby
Journal:  J Natl Cancer Inst       Date:  2007-09-25       Impact factor: 13.506

10.  American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected].

Authors:  Douglas K Rex; David A Johnson; Joseph C Anderson; Phillip S Schoenfeld; Carol A Burke; John M Inadomi
Journal:  Am J Gastroenterol       Date:  2009-02-24       Impact factor: 10.864
View more
  2 in total

1.  Fecal occult blood testing for the prediction of small-bowel pathology detected by capsule endoscopy: a systematic review and meta-analysis.

Authors:  Diana E Yung; Sanju Vijayan; Tomer Avni; Sarah Douglas; Uri Kopylov; Anastasios Koulaouzidis
Journal:  Ann Gastroenterol       Date:  2017-01-05

2.  Predicting pathology on small bowel capsule endoscopy: a good FIT.

Authors:  Ciaran Judge; Donal Tighe; Lillian Barry; Julie O'Neill; Jenny Wong; Amir Shahin; Neil Moran; Roisin Stack; Mary Hussey; Niall Breslin; Anthony O'Connor; Barbara Ryan; Martin Buckley; Deirde McNamara
Journal:  Endosc Int Open       Date:  2019-10-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.